Cat. #156406
R-3327-AT-1 cell line
Cat. #: 156406
Unit size: 1x10^6 cells / vial
Disease: Cancer
Model: Cancer Model
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: John Isaacs
Institute: Johns Hopkins University
Tool Details
*FOR RESEARCH USE ONLY
- Name: R-3327-AT-1 cell line
- Disease: Cancer
- Model: Cancer Model
- Description: AT-1 originates from the spontaneous tumor (R3327) of the prostate identified by W.F. Dunning in a 22 month-old inbred Copenhagen male rat in 1961. R3327 has been maintained by continuous serial passage in rats for many years. In the course of the passage of the H subline in intact (i.e. not castrated) male rats, random tumor progression occurred due to the genetic instability of the tumor in an occasional rat, giving rise to fast growing anaplastic tumors within a single passage. AT-1 was the first of such anaplastic tumors to arise. Following subcutaneous transplantation in syngeneic male rats, AT-1 forms solid sheets of malignant cells with no indication of glandular function. These tumors are androgen-independent and grow continuously with a doubling time of approximately 2.5 days. AT-1 exhibits a low metastatic ability (<5% of rats inoculated sub-cutaneously develop distant metastases). The AT-1 subline can be used to study the effects of various types of cancer therapies on prostate cells.
- Cellosaurus id: CVCL_3568
Target Details
- Target: Forms metastatic anaplastic tumors
Handling
- Format: Frozen
- Unit size: 1x10^6 cells / vial
- Shipping conditions: Dry ice
References
- Isaacs et al. 1988. Prostate. 13(2):165-88. PMID: 3174494.
- Isaacs et al. 1986. Prostate. 9(3):261-81. PMID: 3774632.
